Hanmi Pharmaceutical Co.Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss 2024-11-06 15:41
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Hanmi Fine Chemical Launches 'high-tech CDMO' Business 2022-05-23 08:32
Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide" 2021-06-29 21:00
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs 2021-01-18 22:00
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline" 2020-01-16 07:30
1